medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2017, Number 4

<< Back Next >>

Rev Latin Infect Pediatr 2017; 30 (4)

SLIPE position document about dengue vaccine

Language: Spanish
References: 4
Page: 136-138
PDF size: 166.04 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Gaillardou S, Skipetrova A, Dayan GH, Jezorwski J, Saville M, Van der Vliet D et al. Safety overview of a recombinant live-attenuated tetravalent dengue vaccine: pooled analysis of data from 18 clinical trials. PLoS Negl Trop Dis. 2016; 10 (7): e0004821. doi: 10.1370/journal.pntd.0004821, July 14, 2016

  2. Arredondo JL et al. Long term safety (year 5) of the recombinant life attenuated chimeric yellow fever dengue virus tetravalent dengue vaccine (CYD-TDV) in phase III efficacy trials. ASTMH, Baltimore, 2017.

  3. Arredondo JL et al. Long term safety (year 5) of the recombinant life attenuated chimeric yellow fever dengue virus tetravalent dengue vaccine (CYD-TDV) in phase III efficacy trials. SLIPE XVII Congress, Cancun Mexico, Nov. 8-11, 2017.

  4. Versión en inglés: http://www.slipe.org/DENGUE_actualizacion2018.pdf




2020     |     www.medigraphic.com